The hugely expensive multi-step acquisition of Alcon from Nestlé and minority shareholders (#msg-45072999) must rank as one of the worst M&A transactions in the drug/biotech industry during the past decade.
“The efficient-market hypothesis may be the foremost piece of B.S. ever promulgated in any area of human knowledge!”
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.